Zhuhai Sailong Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2024: 1.19%

Zhuhai Sailong Pharmaceutical Co Ltd (002898) has an Asset Resilience Ratio of 1.19% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥10.00 Million

≈ $1.46 Million USD Cash + Short-term Investments

Total Assets

CN¥841.08 Million

≈ $123.08 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2023)

This chart shows how Zhuhai Sailong Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Check Zhuhai Sailong Pharmaceutical Co Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Zhuhai Sailong Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Zhuhai Sailong Pharmaceutical Co Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥10.00 Million	1.19%
Total Liquid Assets	CN¥10.00 Million	1.19%

Asset Resilience Insights

Limited Liquidity: Zhuhai Sailong Pharmaceutical Co Ltd maintains only 1.19% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhuhai Sailong Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhuhai Sailong Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	0.05%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Syndax Pharmaceuticals Inc NASDAQ:SNDX	Biotechnology	46.79%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	63.47%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for Zhuhai Sailong Pharmaceutical Co Ltd (2020–2023)

The table below shows the annual Asset Resilience Ratio data for Zhuhai Sailong Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	0.26%	CN¥2.14 Million ≈ $313.68K	CN¥813.84 Million ≈ $119.09 Million	+2.33pp
2022-12-31	-2.07%	CN¥-17.52 Million ≈ $-2.56 Million	CN¥847.99 Million ≈ $124.09 Million	-0.04pp
2021-12-31	-2.03%	CN¥-17.89 Million ≈ $-2.62 Million	CN¥882.78 Million ≈ $129.18 Million	--
2020-12-31	0.00%	CN¥0.00 ≈ $0.00	CN¥813.96 Million ≈ $119.11 Million	--

pp = percentage points

About Zhuhai Sailong Pharmaceutical Co Ltd

SHE:002898 China Biotechnology

Market Cap

$9.53 Million

CN¥65.12 Million CNY

Market Cap Rank

#27152 Global

#4746 in China

Share Price

CN¥0.37

Change (1 day)

-2.63%

52-Week Range

CN¥0.32 - CN¥16.81

All Time High

CN¥29.47